Why is C3 and C4 complement so important in the diagnosis and treatment of systemic lupus erythematosus?
ARD: Anti-RNP antibodies in systemic lupus erythematosus are associated with an interferon gene signature independent of reduced complement levels
JCLA: Comparison of ELISA and Dot Blot for the Detection of Graves' Disease TSH Receptor Antibodies
to complement each other's advantages in materials, chemicals, chemistry and ICT
Rapid detection of Staphylococcus aureus enterotoxin in fresh milk (ELISA method)
Express Beihai Kangcheng's complement inhibitor has positive preliminary clinical results
Positive preliminary clinical results of Beihai Kangcheng complement inhibitor
ESR, complement, important indicators of systemic lupus erythematosus activity!
Challenge AstraZeneca's first new category of complement drug Aspaveli in more than ten years to obtain approval!
AstraZeneca's new indications for major complement C5 inhibitors receive FDA priority review qualification
First in class oral complement C5aR inhibitor approved in Japan
Novartis's first complement factor B inhibitor iptacopan has been certified by the British Innovation Passport
Novartis' potential "first-in-class" complement inhibitor reaches phase 2 clinical endpoint
Phase 3 clinical results of C3 complement inhibitors for the treatment of age-related macular degeneration released
Express U.S. FDA approves the first oral complement 5a receptor inhibitor
Oral complement C5a receptor inhibitor approved in Japan
, and the advantages of multiple disciplines complement each other to overcome diagnostic problems!
agents and traditional treatment methods complement each other
Front Immunol: In SARS-CoV-2 infection, excessive activation and consumption of complement can increase hospital mortality!
Single-base editing company Beam and Apellis collaborate to develop gene editing therapies for complement diseases